Grifols | GRFS - Resultado Líquido





Resultado Líquido Alterar Data
Alaunos Therapeutics USD -952K 54K 2026-06
Arca Biopharma USD -31.82M 2.24M 2026-03
aTyr Pharma USD -134K 19K 2026-06
Bio Path USD -270K 706K 2026-03
Brainstorm Cell Therapeutics USD -2.13M 21K 2026-03
Capricor Therapeutics USD -30.17M 5.6M 2025-12
Cara Therapeutics USD -6.8M 1.28M 2026-03
GlaxoSmithKline GBP 1.54B 1.11B 2026-09
Grifols EUR 114.37M 34.03M 2025-12
Immunic USD -19.3M 6.28M 2025-12
Minerva Neurosciences USD 1.44M 21.07M 2024-12
Nektar Therapeutics USD -44.9M 8.82M 2026-03
Sangamo BioSciences USD -36.13M 12.96M 2024-06
TherapeuticsMD USD -1.09M 356K 2024-06